Trials / Completed
CompletedNCT00000219
Buprenorphine Dose Alteration Study - 1
Buprenorphine Dose Alteration Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- University of Vermont · Academic / Other
- Sex
- Male
- Age
- 19 Years – 41 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effects in buprenorphine dose alterations in opioid dependent individuals being maintained on buprenorphine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine |
Timeline
- Start date
- 1991-12-01
- Completion
- 2001-07-01
- First posted
- 1999-09-21
- Last updated
- 2016-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000219. Inclusion in this directory is not an endorsement.